International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-6 doi: 10.5281/zenodo.14228297
Original Research Article
To Correlate Traumatic Optic Neuropathy with Traumatic Brain Injury in Patients with Road Traffic Accidents -A Cross-Sectional Study
Published
Nov. 27, 2024
Abstract

Background: Traumatic optic neuropathy (TON) is a potential complication of traumatic brain injury (TBI) in patients with road traffic accidents (RTAs). This study aimed to investigate the correlation between TON and TBI severity and evaluate the fundoscopic changes and visual outcomes in these patients.Methods: A cross-sectional study was conducted on 30 patients with TON following RTAs. The type of TON (direct or indirect) was assessed, and the severity of TBI was categorized based on the Glasgow Coma Scale (GCS) score. Fundoscopic changes and visual acuity were evaluated and compared between TON types and TBI severity groups.Results: Indirect TON was more common (63.3%) than direct TON (36.7%). Direct TON was significantly associated with severe TBI (75.0%), while indirect TON was more prevalent in mild (77.8%) and moderate (76.9%) TBI (p=0.041). Optic disc edema was more frequent in direct TON (72.7%) than in indirect TON (31.6%) (p=0.027). Visual acuity was significantly worse in direct TON compared to indirect TON (p=0.027). Conclusion: The type of TON is significantly associated with the severity of TBI in patients with RTAs. Direct TON is more common in severe TBI and is associated with worse visual acuity and a higher prevalence of optic disc edema compared to indirect TON. Comprehensive ophthalmic evaluation is crucial in patients with TON and TBI to ensure early diagnosis and appropriate management.

Recommended Articles
Loading Image...
Volume-5, Issue-6
Citations
2337 Views
453 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved